PhaseRx Secures $5,200,053 New Round

  • Feed Type
  • Date
    7/9/2012
  • Company Name
    PhaseRx
  • Mailing Address
    410 West Harrison Street Seattle, WA 98119
  • Company Description
    The company is developing therapies via sIRNA technologies.
  • Website
    http://www.phaserx.com
  • Transaction Type
    Debt
  • Transaction Amount
    $5,200,053
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filings – amended.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.